- Available:In stock821
- Availability date:2020-07-30
- Dosage form:Drops (Bottle)
- In stock:824 Items
The complex homeopathic medicine Incena has a systemic effect due to the combination and mutual strengthening of the active components. It has anti-inflammatory, analgesic, desensitizing, immunomodulating and reparative effects. inhibits the synthesis of inflammatory mediators, slows down the accumulation of macrophages and white blood cells in the focus of inflammation. reduces capillary permeability and prevents the appearance of edema. improves the rheological properties of blood by reducing platelet aggregation. reduces all phases of development and the severity of the inflammatory process. does not have a mineralocorticoid effect.
In patients with a surgical profile, it accelerates the purification of the wound surface from purulent discharge, stimulates the healing process. It improves renal function with concomitant chronic renal failure on the background of secondary amyloidosis.
The inclusion of the drug in the basic therapy of patients with rheumatoid arthritis ensures the rapid achievement of analgesic and anti-inflammatory effects, allows you to reduce the dose or even refuse to take synthetic NSAIDs. The drug significantly improves the general condition and performance of patients, reduces the severity of morning stiffness, reduces the intensity of pain and the degree of swelling of the affected joints, helps to normalize laboratory parameters (primarily ESR), significantly improves the quality of life of patients with inflammatory and degenerative diseases of the musculoskeletal system .
Acute and chronic inflammatory and degenerative diseases of the musculoskeletal system and soft tissues, accompanied by pain: arthritis, osteoarthritis, polyarthritis, arthrosis, osteochondrosis, injuries, wounds, including postoperative ones, with a tendency to suppuration. as part of the complex therapy of collagenoses (rheumatoid arthritis, systemic lupus erythematosus), glomerulonephritis, rheumatism, dermatomyositis.
Adults and children over the age of 12 years: 10 drops of the drug in its pure form or diluted in 1 tablespoon of water; children aged 5-12 years: 5-7 drops of the drug, diluted in 1 tablespoon of water; children aged 1 year – 4 years: 1–4 drops of the drug, diluted in 1 teaspoon of water. take the drug 3 times a day.
At the beginning of treatment, as well as in cases requiring a rapid decrease in the severity of the symptoms of the disease, it is possible to take the drug every 30 min – 1 h up to 8 times a day until the condition improves, but no more than 3 days, with the transition to the standard (three-time) administration of the drug.
To increase effectiveness, it is recommended to take the drug in between meals (30 minutes before or 1 hour after eating), holding it for a while in the mouth before swallowing.
The main course of treatment is 2-3 months. With the stabilization of the state, a transition to a maintenance dose is possible (2 times a day).
Hypersensitivity to any of the components of the drug.
Not identified. in exceptional cases, people with hypersensitivity to any component of the drug may experience allergic reactions.
At the beginning of treatment, a short-term slight increase in the severity of the symptoms of the disease is possible, which indicates the effect of the drug and does not require withdrawal or correction of its dose. the lack of improvement within 5-7 days of self-administration indicates a possible improper use of the drug. in this case, consult a doctor.
Since the Inzena preparation contains plant and other natural components, slight changes in the taste, transparency or color of the solution are possible during storage, which does not lead to a decrease in the effectiveness of the drug.
Use during pregnancy and lactation.Information about any risk to the fetus or infant in the case of using the drug during pregnancy and lactation has not yet been recorded, but the advisability of prescribing the drug during this period is determined by the doctor, taking into account the benefit / risk ratio.
Children. The drug is used in children aged 1 year.
The ability to influence the reaction rate when working with vehicles or other mechanisms. The drug does not have a sedative effect and does not affect the ability to drive vehicles or mechanisms.
Clinically significant interaction with other pharmacological agents has not been established. the drug can be combined with any medications and treatment methods.
With the simultaneous use of the drug with NSAIDs, the intake or dose of the latter can be reduced after consulting a doctor.
Cases are unknown.
In a tightly closed bottle, in the original packaging, at a temperature not exceeding 30 ° c out of the reach of children.